Tags : Marathon Venture Capital

BioTech

Causaly secures £12 million Series A investment led by Index

Causaly raises $17 million to accelerate biomedical research and discovery of scientific breakthroughs London, 19 May 2021 – Causaly, the London-based company that allows researchers and specialists to intuitively map and navigate the intricate landscape of biomedical research, has raised $17 million from investors to grow its team and expand into new markets. Venture capital […]Read More